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Major depressive disorder (MDD) is the most severe depression type and one of the
leading causes of morbidity worldwide. Animal models are widely used to understand
MDD etiology, pathogenesis, and treatment, but the efficacy of this research for
patients has barely been systematically evaluated. Such evaluation is important given
the resource consumption and ethical concerns incurred by animal use. We used the
citation tracking facilities within Web of Science and Scopus to locate citations of original
research papers on rats related to MDD published prior to 2013—to allow adequate time
for citations—identified in PubMed and Scopus by relevant search terms. Resulting
citations were thematically coded in eight categories, and descriptive statistics were
calculated. 178 publications describing relevant rat studies were identified. They were
cited 8,712 times. More than half (4,633) of their citations were by other animal studies.
794 (less than 10%) were by human medical papers. Citation analysis indicates that rat
model research has contributed very little to the contemporary clinical understanding
of MDD. This suggests a misuse of limited funding hence supporting a change in
allocation of research and development funds targeting this disorder to maximise
benefits for patients.
Keywords: major depressive disorder, animal models, animal use alternatives, citation analysis, rat
INTRODUCTION
Depression is the leading cause of disability worldwide (World Health Organization, 2019).
Nowadays, it is judged to affect more than 320 million people of all ages and genders (Vos et al.,
2016), even though it is more frequent in women than man (Ferrari et al., 2013).
Currently, and according to DSM-5 (American Psychiatric Association, 2013), there are
eight main forms of depression: major depressive disorder (MDD), persistent depressive
disorder, premenstrual dysphoric disorder, disruptive mood dysregulation disorder,
substance/medication-induced depressive disorder, depressive disorder due to another
medical condition, non specified depressive disorder, and other specified depressive disorder.
MDD is the most severe, prevalent, and disabling depression type (Malhi and Mann,
2018). It is characterized by a persistent depressed mood or loss of pleasure, along with
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four out of the following symptoms: significant weight loss
or gain; insomnia or hypersomnia; psychomotor agitation or
retardation; fatigue or loss of energy; feelings of worthlessness
or excessive or inappropriate guilt; diminished ability to think,
concentrate, or make decisions; recurrent thoughts of death
(American Psychiatric Association, 2013). For MDD to be
diagnosed, the patient needs to fulfill five diagnostic criteria out of
a pool of nine, which means that the same disorder may present
differently in different subjects (Kaufman, 2018). The variety of
both symptoms and biomarkers has led to the recent suggestion
that there might be several subtypes of MDD (Beijers et al., 2019).
MDD etiology is not completely understood yet. Most
authors agree that there is a combination of biological and
environmental factors that determine the triggering of the
disorder (Mandelli and Serretti, 2013). Biological factors to take
into account include genes, neurotransmitters, and hormones,
while environmental factors include childhood trauma, stressful
life events, sexual abuse, low educational attainment, and
differences in personality traits.
Evidence suggests that there are genetic factors involved,
but even though more than 100 candidate genes have been
investigated, a clear connection between specific genes and
MDD has not yet been established (Shadrina et al., 2018).
Furthermore, studies suggest that variations in different genes,
each with a minor effect, combine to increase the risk of
developing this disorder (Wray et al., 2018). Most studies
suggest that MDD patients have imbalanced brain chemistry at
neurotransmitters level (Beijers et al., 2019). Among those, the
majority of the studies indicate dopamine, norepinephrine, and
serotonin as the most implicated in MDD etiology (Belujon and
Grace, 2017). Others stress the involvement of glutamate (Réus
et al., 2018). Nonetheless, some studies find no differences in
neurotransmitters between MDD patients and healthy controls
(for a review, see Beijers et al., 2019). Similarly, it is widely
accepted that hormones play a role in MDD etiology (Druzhkova
et al., 2019) but there is no clear-cut connection between a specific
hormone secretion and MDD. For example, Asadikaram et al.
(2019) found differences between MDD patients and healthy
controls in hormone levels of adrenocorticotropic hormone,
testosterone, thyroid–stimulating hormone, free thyroxine index,
and cortisol/dehydroepiandrosterone sulfate (DHEA–S), while
others consider vasopressin and oxytocin to play a pivotal role
in MDD etiology (for a review, see Iovino et al., 2018).
Recent studies also suggest that there is a link between
inflammation and MDD, suggesting that MDD has an
inflammatory subtype (Beijers et al., 2019), but the claims
that inflammation has a role in etiology of MDD are still
being disputed (Miller, 2018). The same happens with changes
in gut microbiome in MDD patients (Winter et al., 2018).
While the link between gut microbiome and depression is well
documented, the question of the causality in the connection
between the two remains to be robustly answered (Winter et al.,
2018). It is important to mention that these patterns may be true
for all biological changes found in MDD patients. It is almost
impossible to determine if the biological changes caused MDD
or if MDD caused the biological changes. Conversely, most
environmental factors involved in MDD are definitely a primary
cause. In this regard, the big unanswered question that remains
is why does the same life event trigger MDD in one person
and not in another.
Among the most documented environmental factors linked
to MDD are childhood traumas, which also cause biological
changes in the brain of MDD patients (Yu et al., 2019), stressful
life events, sexual abuse, low educational attainment (Peyrot
et al., 2013), and personality traits (Bensaeed et al., 2014).
Other disorders and traits are also strong predictors for MDD.
For example, a big longitudinal study showed that people who
present anxiety traits in their twenties are more prone to
develop MDD in their thirties (Gustavson et al., 2018). Also
Parkinson’s, Migrains’, Alzheimer’s patients, among others, have
high prevalence of MDD (Ketharanathan et al., 2014; Muneer
et al., 2018; Tao et al., 2019).
It is not always possible to determine a proximal cause.
MDD may have seasonal or peri-partum onset, as well as
being induced by other disorders (e.g., Parkinson’s) or substance
ingestion, but it can also emerge without an obvious reason
(American Psychiatric Association, 2013).
Major depressive disorder pathogenesis is as diverse as its
etiology. Even though there are several different treatment
courses available (for a review, see for example Pandarakalam,
2018), 50–60% of patients develop treatment resistant depression,
i.e., do not enter remission even after trying different courses of
treatment (Kraus et al., 2019), and only 52% of patients achieve a
full recovery (Novick et al., 2017).
Due to its complexity, MDD is particularly hard to study, but
its severity, prevalence, and significant economic burden make it
a moral and social imperative to keep investing this research field.
Yet, its research funding has been scarce when compared to other
disorders (e.g., cancer) (Ledford, 2014).
Randomized controlled trials (RCTs) are considered to be
the gold standard for empirical research (Hariton and Locascio,
2018), namely, in MDD’s potential treatments and interventions
(Monsour et al., 2019) but they are unsuitable for all purposes.
Some authors consider observational longitudinal studies to be
more useful in understanding the etiology and pathogenesis of
human disorders (Frieden, 2017) pointing out that they also
overcome ethical and practical limitations of RCTs such as the
insufficient study duration or the disregard of unpredictable
variables that affect patients in their daily lives (Song and Chung,
2010). Others stress the importance of basic and applied research
aiming to understand MDD’s mechanisms in a controlled
environment (e.g., Papassotiropoulos and De Quervain, 2015).
In this regard, advanced magnetic resonance imaging
techniques used in patients and healthy controls can be
a powerful tool regarding the physiological and metabolic
characterization of brain tissue, in the same way that single
photon emission computed tomography and positron emission
tomography imaging modalities provide valuable data on brain
function and activity (Tsougos et al., 2019).
Post-mortem studies as well as cell-based disease modeling
are another valuable set of tools in understanding the biology of
psychiatric disorders. As cellular biology techniques evolve new
ways to generate and preserve human cells in vitro emerge (e.g.,
induced pluripotent stem cells, trans differentiation technologies
Frontiers in Psychology | www.frontiersin.org 2 July 2020 | Volume 11 | Article 1486
fpsyg-11-01486 July 11, 2020 Time: 18:56 # 3
Carvalho et al. Contribution Rat Studies to MDD
for deriving neurons from adult humans, Vadodaria et al., 2018).
However, they are insufficient to fully understand the pathways
and progression of complex disorders. Some authors assert that
systems biology might be the answer as it can integrate and
model different levels of human experimental data—molecular,
cellular, tissue, organ, clinical, and population disorders (Langley,
2014). Others suggest a mind-brain paradigm that combines
simultaneous use of imaging techniques with the use of scales
and/or other tests validated for psychodiagnostics as a way to
build a bridge between neuroscience and psychological sciences
to study mental disorders (Stoyanov, 2009). Others claim that
the only way to overcome such limitations is by resorting to
animal models, which are seen by some as crucial for MDD
research (e.g., Wang et al., 2017; Akil et al., 2018), despite their
well-recognized limitations with respect to human predictability
(Akil et al., 2018).
To overcome these limitations, combinations of different
animal models are proposed (Akil et al., 2018), different
transgenic lines of rats are generated (as described by Bailey,
2019) and efforts are made to overcome the biological differences
between species that keep emerging as extrapolation barriers
(Hodge et al., 2019). All the above involve high economic costs
and consume a tremendous amount of animal lives. The reason
behind this is because it is assumed that animal use is unavoidable
and its withdrawal would jeopardize human health. However,
very few studies have addressed the contribution of animal
models to MDD research through significant critical scrutiny
within peer-reviewed literature. Specifically, to our knowledge,
the contribution of rats for this aim has never been evaluated
in such terms, even though rodents are undoubtedly the most
frequently used animals regarding this context. Even though mice
are by far the most used rodents in biomedical research, an
initial search in PubMed, a search engine that comprises more
than 30 million biomedical literature publications, indicated that
species within genus Rattus were highly used in MDD research,
which made them an interesting case study. To evaluate the
contribution of animal models to MDD research is important
for ethical and economic reasons. As a society, we should make
an informed decision on whether we should proceed improving
animal models until we find a suitable one or if we should halt the
current paradigm and invest more in other methods that might be
more promising as well as cheaper and less ethically contentious
(Carvalho et al., 2019).
To conduct such evaluation, we performed a citation analysis
on original publications describing rat data within MDD
research. A citation analysis as defined by Garfield and Merton
(1979) consists of determining the number of citations target
papers (in this case original papers using rat models to study
MDD) receive, as well as determining citation patterns—in this
case which sort of papers are citing the target papers (e.g.,
animal research papers, human research papers, review papers).
Granting that the studies cited guide and influence authors’
work (Burright et al., 2005) and that citation level has been
related to clinical relevance in the past (Pound and Nicol, 2018),
such citation analysis can be used as an indicator to evaluate
the contribution of rat studies to current clinical knowledge in
MDD, as has been done for other disorders (e.g., Knight, 2007;
Long et al., 2014; Carvalho et al., 2016) as well as for other species
in regard to MDD research (Carvalho et al., 2019).
If rat studies are informing the human medical research
community, then we would expect that:
1. Most of the papers would be cited at least once in
subsequent human medical papers;
2. The proportion of citations by human medical papers
would be substantially higher when compared to other
research categories.
METHODS
The citation analysis was performed between January and August
of 2019. PubMed and SCOPUS were searched for publications
using rat models to investigate MDD. We searched PubMed
using Medical Subject Heading search terms (MeSH terms):
“Depressive Disorder, Major” AND “rat” OR “rodent.” MeSH
terms are a comprehensive list of key terms made available
by PubMed designed to identify all relevant studies in an
area (Uman, 2011). So, searching for “MDD” retrieves other
nomenclatures for the same disorder such as melancholia.
Similarly, the search term “rat” retrieves papers using all rat
species. We used PubMed filters to exclude review articles
(“review,” “systematic review,” “meta-analysis,” “bibliography”)
as well as opinion articles (“biography,” “auto-biography,”
“comment,” “editorial,” “interview”). Since Scopus does not have
the MeSH term tool, we used the search terms “MDD” AND
(“rat” OR “rattus”) in the search fields. We included journal
papers, books, research reports, and conference proceedings
written in English or Portuguese, which are within our language
proficiencies. We restricted our search to publications prior to 31
December 2013, to allow adequate time for citation of articles to
occur. We did not include a lower date limit.
Since our goal was to evaluate the contribution of animal
models—particularly rat models—to current clinical knowledge
of MDD, we manually excluded from our analysis all the papers
that reported animal and human data, as well as papers reporting
other species’ data (e.g., mice). Hence, we included only original
papers focused on MDD, exclusively using data obtained from
rats. We excluded papers describing other disorders, data from
other species along with data from rats, and papers that did not
present first hand data (e.g., review papers). Out of 237 papers
originally located through the search engines’ filters, we manually
excluded 59 because they met exclusion criteria.
The retrieved papers were subjected to a subsequent citation
analysis using the cited reference search facility within Scopus
and Web of Science.
Web of Science is a major scientific citation indexing service
that encompasses over 50,000 scholarly books, 12,000 journals,
and 160,000 conference proceedings. Scopus is the largest citation
database; it covers nearly 36,377 titles from approximately
11,678 publishers.
For each rat study, we recorded the total number of times it
was cited, and allocated each citation to one or more of seven
categories, defined prospectively:
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– Animals. This category included all animal studies from
observational ethological studies to invasive procedures
as defined by Knight (2011), i.e., interfering with bodily
integrity (whether through puncture or incision) or
production of genetically modified animals. This category
also included severe procedures (as defined by current
European Legislation Directive 2010/63/EU) commonly
used in mental disorder research such as inescapable
electroshock or isolating social animals for long periods.
We recorded within this category which animal papers
focused on MDD and which focused on other subjects.
– Humans. This category included papers that used human
participants. They included clinical or treatment trials
(either drug trials or non-pharmacological treatments),
papers aiming to explore psychological, social, biochemical,
physiological, genetic, or neurological variables related to
MDD or other human disorders; as well as papers aiming
to understand the relationship between MDD and other
disorders (co-morbidities) in human patients. We recorded
within this category which human papers focused on MDD
and which focused on other disorders.
– Reviews. This category included narrative reviews,
systematic reviews, meta-analysis, as well as extensive
opinion papers that did not report original empirical
data. We included reviews focused on animals and
on humans alike.
– Editorials. This category included editorials, comments,
and clinical guides.
– In vitro. This category included exclusively cell-line data.
Whenever the source of the tissue or cell was a human
participant (either alive or post-mortem) or a laboratory
animal killed for such purpose the paper was allocated into
“human paper” or “animal research paper,” respectively.
– In silico. This category included data obtained via computer
simulations of human data.
– Social. This category included human surveys or other
social perception papers.
Whenever it was not possible to define the category of the
citing paper (due to language barriers—i.e., papers written in a
language that was not English or Portuguese—or absence of the
abstract), the paper was denoted “not available” and removed
from the sample. If more than one category could be assigned to
a citing paper (e.g., animal research and human paper), then that
paper was allocated to every appropriate category.
To evaluate if the proportions of citations made by human
publications and animal publications on MDD were different,
we used a t-test. Results were considered statistically significant
when P < 0.05. The analyses were performed in R 3.6.1
(R Core Team, 2019).
RESULTS
The 178 original rat studies focused on MDD that were published
before the end of 2013 were cited 8,712 times by August 2019.
Of these 178, 87 (49%) studies were never cited in subsequent
publications describing human studies on MDD, and 53 (30%)
were never cited in any publications related to human research,
either focused on MDD, or on other disorders such as post-
traumatic stress disorder or bipolar disorder.
As shown in Figure 1, rat studies were mainly cited by
other animal research papers (4,641), followed by review papers
(2,909), human studies (794), in vitro papers (211), editorials (58),
in silico papers (57), and human social papers (one). 230 citations
were unavailable to us due to access or language barriers. These
were removed from further analysis.
The proportion of citations by human medical papers was
9.1% while the proportion of citations by animal papers was
53.3%. This corresponds to a mean difference between the
proportions of citations by human and by animal papers of−46%
(p < 0.001). Beyond the statistical significance, this is certainly a
considerable practical difference that reflects almost 100∗(53.3–
9.1)/53.3 less citations by human papers than by animal papers.
DISCUSSION
The majority of the rat papers located in this study were cited by
subsequent animal research papers, but about half (49%) of the
original papers retrieved were never cited in subsequent papers
related to MDD in humans, and in fact about a third (30%) were
never cited in any subsequent human studies.
Our citation analysis revealed that only around a tenth (9.1%)
of the total number of citations were by human medical papers.
This result contradicted the hypothesis that the proportion of
citations by human medical papers would be substantially higher
when compared to other research categories. This hypothesis was
based on the assumption that animal models are essential to
clinical research, as promulgated by several authors (e.g., Wang
et al., 2017; Akil et al., 2018). Hence, our results raise doubts about
the justification for these animal studies.
The results of our study are in agreement with previous studies
that empirically evaluated the contribution of animal models to
human healthcare either through citation analysis (e.g., Shapiro,
1998; Knight, 2007; Long et al., 2014; Carvalho et al., 2016) either
through other methods such as systematic reviews (e.g., Perel
et al., 2007), social science studies (e.g., Shapiro, 1998; Compton
et al., 2019), historical analysis (e.g., Menache, 2012), among
others (for an extensive review on this topic see, for example,
Knight, 2019).
This suggests that biomedical research resorting to animal
models is not normally considered significant, or particularly
visible to, the human medical research community.
Supporters of animal models of human disorders claim
that this happens: (a) due to differences in the way basic
animal work and human clinical trials are conducted, and
propose a change to a translational biomarker-based approach
within early steps of pre-clinical research (Garner, 2014);
or that this occurs (b) due to failings in study design,
conduct, analysis, and reporting (as described by Pound and
Ritskes-Hoitinga, 2018), which could be resolved with better
reporting and better methodological quality (as proposed by
Fabian-Jessing et al., 2018).
Frontiers in Psychology | www.frontiersin.org 4 July 2020 | Volume 11 | Article 1486
fpsyg-11-01486 July 11, 2020 Time: 18:56 # 5
Carvalho et al. Contribution Rat Studies to MDD
FIGURE 1 | Frequency of citations by category established in this study.
Opponents of the use of animal models point out that
animal models lack external validity, i.e., findings derived
in one setting, population, or species cannot be reliably
applied to other settings, populations, and species, which is
unavoidable since animal models: (a) oversimplify complex
human disorders and the conditions in which they occur
(Stoyanov, 2009; Pound and Ritskes-Hoitinga, 2018); (b) are
unsuitable models due to species differences, proposing as
a possible solution a shift toward human-based non-clinical
research (Pound and Ritskes-Hoitinga, 2018).
This paradigm change toward human-based research is
gaining more and more supporters both for ethical and scientific
reasons (e.g., LaFollette and Shanks, 1995; Langley, 2014; Pound
and Ritskes-Hoitinga, 2018; Ram, 2019). But the resistance from
animal researchers in face of this shift remains significant and is
evident not only in the slowness to recognize the growing body
of evidence against the use of animals as models, but also in the
emphasis placed on refinement of animal use (Franco and Olsson,
2014) (the third R as defined by Russell and Burch, 1959, instead
of on the first and most important R—replacement with non-
animal alternatives). Considering this, Frank (2005) proposed
that animal experimentation constitutes a good example of path
dependency, which is a well-documented phenomenon that
states that what has occurred in the past persists because of
resistance to change.
Our results also show that more than half (53%) of the
citations our target papers received were by subsequent animal
papers, which strengthens the likelihood of the path dependency
phenomenon described above. It can be argued that there is a
need to have a substantial amount of animal research before
achieving a critical mass that can lead to useful breakthroughs
in human health, which might explain the high level of citations
of animal papers by subsequent animal papers. Nonetheless, it
does not explain the low level of citations by human papers,
especially when this does not appear to be a trend in human-
based approaches (in vitro and in silico) which received more
citations by human medical papers in a small study previously
conducted (Carvalho et al., 2019). Furthermore, a recent citation
analysis in another field of human health research also found
in vitro papers to be the most cited papers, above reviews, and
animal experimentations papers (Adnan and Ullah, 2018).
We acknowledge that this study has certain limitations.
Even though we used two very large bibliographic databases to
attempt to locate all publications that met our search criteria, we
acknowledge that a small minority of relevant papers may not
have been retrieved (e.g., due to labeling errors) or may have been
excluded due to human error, as only one person selected which
retrieved papers met exclusion criteria.
Similarly, we did not take note of certain citations such as self-
citations, in-house citations (i.e., citations by colleagues from the
same insitution), and content-irrelevant citations (e.g., the paper
is cited for other reasons other than its content). Such citation
types were not considered significant in several studies and were
similarly dismissed in recent studies (Huang et al., 2019).
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Also, we did not analyze the quality of citing papers
as in previous studies (Carvalho et al., 2016, 2019). This
might have resulted in an even lower, but a truer, indication
of the contribution of rat models for current clinical
knowledge of MDD, given that not all were likely of high quality.
Finally, we acknowledge that being cited by human medical
papers is not the only indicator of the clinical usefulness of
research. Uncited studies may also contribute, for example,
through direct transfer of knowledge between scientists and
clinicians. Most clinicians are not involved in research, i.e., they
do not publish; hence, it is possible that practitioners involved
in the treatment of MMD are informed by or utilize findings
from rat studies through direct transfer of knowledge. A citation
analysis does not measure this effect. However, it is also possible
that clinicians are less aware of research results, than researchers.
Thus, a survey on practitioners—which we did not perform—
would have been an interesting complement to our results.
Review papers on depression that might inspire authors likely
cite animal papers, nonetheless if the animal paper is really
relevant for the authors’ hypothesis or method it is likely the
primary paper will be cited and not solely the review paper
that referred to it.
Citation rates may also be affected by factors such as
article length, number of authors, their country, and university
of affiliation (Leimu and Koricheva, 2005). Despite their
limitations, however, citation frequencies do normally provide
reasonably objective approximation of the importance of research
results within a field. Research that makes a significant
contribution—such as by confirming or refuting important
hypotheses—is likely to be cited by subsequent papers. Research
that is inconclusive or lacking in significance is much less
likely to be cited.
Accordingly, we believe that our citation analysis provides a
valid and critical assessment of the contribution of rat models
to current clinical knowledge of MDD. Such evaluation of the
efficacy of research approaches is important to ensure the most
responsible allocation of research funds and scientific resources,
to maximize the likelihood of clinical benefit to patients, and to
minimize the consumption of animal lives in research where such
benefits are unlikely.
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